Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982188 · ClinicalTrials.gov registry record
Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 104
- Enrollment target
NCT01982188: Completed study, sponsored by Atlantic Health System.
NCT01982188 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01982188 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
This study was designed to evaluate urinary function before and one year after single incision sling placement at the time of robotic sacrocolpopexy. The thought is that the more minimally-invasive, single incision sling would provide a similar subjective success rates as those of retropubic and trans-obturator slings.
Primary Outcome
Subjects will undergo a cough stress test to evaluate for stress urinary incontinence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
What the finished NCT01982188 record still lists
NCT01982188 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01982188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01982188 about?
NCT01982188 is a clinical study titled "Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy". This study was designed to evaluate urinary function before and one year after single incision sling placement at the time of robotic sacrocolpopexy. The thought is that the more minimally-invasive, single incision sling would provide a similar subjective success rates as those of retropubic and tra...
What is the current status of trial NCT01982188?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2012-09. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01982188?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia